Current Edition

CFO

Moderna’s finance head is out as former employer conducts investigation

Dive Brief: Moderna disclosed Tuesday that its recently appointed chief financial officer is leaving the company effective immediately, as his former employer conducts an investigation …

Continue Reading →
children

Moderna, with new data, to seek clearance for COVID-19 vaccine in young children

Moderna on Wednesday said its COVID-19 vaccine spurred strong immune responses in a large study testing the shot in children as young as 6 months …

Continue Reading →
Alnylam

Alnylam sues Pfizer, Moderna over technology used in COVID vaccines

Dive Brief: Alnylam is accusing Pfizer and Moderna of violating a patent it holds for technology that Alnylam claims the two companies use in their …

Continue Reading →
adults

Moderna, citing need for ‘flexibility,’ seeks broad clearance of fourth COVID shot

Dive Brief: Moderna has asked the Food and Drug Administration to clear a fourth dose of its COVID-19 vaccine for adults 18 and over, a …

Continue Reading →
infection

Moderna, on the heels of pharma rivals, cleared to advance RSV vaccine

Dive Brief: Moderna is set to begin late-stage testing of a vaccine to prevent a common respiratory infection, announcing Tuesday that independent data monitors determined …

Continue Reading →
booster

Moderna follows Pfizer in beginning trial of omicron vaccine

Dive Brief: Moderna on Wednesday said it has begun a trial testing a new version of its COVID-19 vaccine that’s tailored to the omicron variant, …

Continue Reading →
flu

Moderna reveals first study results for seasonal flu vaccine

Having proved messenger RNA’s might as a vaccine technology for COVID-19, Moderna aims to prove it can work better than existing shots for countering seasonal …

Continue Reading →
boosters

FDA, aiming to curb another COVID-19 surge, clears Pfizer, Moderna boosters for all adults

The Food and Drug Administration on Friday authorized COVID-19 booster shots for all vaccinated Americans over 18, a move that’s meant to stem a rise …

Continue Reading →
Biotech

Moderna, teaming with a startup, wades further into gene editing

Before it rose to prominence as a vaccine maker, Moderna’s original ambitions were to use its messenger RNA technology — a way to prompt the …

Continue Reading →
coronavirus vaccine

J&J foresees end to not-for-profit sales of coronavirus vaccine

J&J has recorded far fewer sales of its coronavirus vaccine than competitors Pfizer and Moderna, partly due to its not-for-profit pricing but also to a …

Continue Reading →
Africa

Under pressure to share technology, Moderna to build vaccine factory in Africa

The announcement from Moderna comes amid criticism of the drugmaker, and other Western companies with authorized coronavirus vaccines, for not doing more to share their …

Continue Reading →
Centers of Disease Control and Prevention

J&J asks FDA to clear booster dose of its coronavirus vaccine

For the past several months, one of the many questions hanging over the booster debate has ben what do with people who got J&J’s shot. …

Continue Reading →
AstraZeneca

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

The success of the mRNA vaccines developed by Moderna and BioNTech has drawn significant attention, and new funding, to the technology that allows drug developers …

Continue Reading →
Biotech

Moderna founder’s next big play in RNA raises $440M

In about a year’s time, Moderna went from an ambitious company with unproven technology to one of the world’s most highly valued drug developers. Now, …

Continue Reading →
GlaxoSmithKline

Pfizer, marking fast research pace, starts key trial of RSV vaccine

A vaccine against RSV has proven elusive despite decades of attempts. Pfizer is moving at a surprisingly quick pace to catch up to rivals led …

Continue Reading →
BioNTech

FDA grants full approval to Pfizer, BioNTech’s coronavirus vaccine

The Food and Drug Administration on Monday granted full approval to Pfizer and BioNTech’s coronavirus vaccine, a long-awaited decision that government officials hope could help …

Continue Reading →
boosters

Moderna says vaccine protective through six months, but warns boosters needed this fall

Like Pfizer, Moderna is pressing the case for booster shots, although public health officials and experts have not yet agreed on when an additional dose …

Continue Reading →
Expand

Merck, Moderna Expand mRNA Cancer Vaccines Partnership

On May 3, 2018, Merck and Moderna Therapeutics, a biotechnology company focused on messenger RNA (mRNA) drug discovery and drug development, announced an expansion of …

Continue Reading →